ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership9,035 shares
Latest Disclosed Value $ 694,792
Neuberger Berman Group LLC reports 40.75% decrease in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 9,035 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $694,792 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 15,250 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -40.75% during the quarter. The current value of the position is $732,829 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ANI PHARMACEUTICALS Common 00182C103 9,035 -6,215 -40.75 695 -42.31 0.0003
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS Common 00182C103 15,250 8,181 115.73 1,204 85.94 0.0009
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS Common 00182C103 7,069 1,146 19.35 648 67.62 0.0005
2025-08-25 2025-06-30 13F/A-1 ANI PHARMACEUTICALS Common 00182C103 5,923 597 11.21 386 8.43 0.0003
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS Common 00182C103 5,923 597 386 0.0002
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS Common 00182C103 5,326 -138 -2.53 357 17.88 0.0003
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS Common 00182C103 5,464 -85 -1.53 302 -8.76 0.0002
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS Common 00182C103 5,549 24 0.43 331 -5.70 0.0003
2024-11-14 2024-06-30 13F/A-1 ANI PHARMACEUTICALS Common 00182C103 5,525 5,525 352 0.0003
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS Common 00182C103 5,525 5,525 352 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.